Mrs. Betty J Delaere, M.A., L.P.C., N.C.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 9844 Dixie Highway, Fair Haven, MI 48023 Phone: 586-716-7600 Fax: 586-716-7659 |
News Archive
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.
Velocity Technology Solutions, Inc. a leader in cloud-based enterprise software hosting, application management, and consulting services, announced today that it was selected by the St. Charles Health System, Inc. to host and fully-manage its Lawson enterprise resource planning applications and Kronos time and labor management applications. Velocity's expertise and demonstrated leadership in supporting the Lawson and Kronos applications, as well as its partnership with both software providers, were driving forces behind St. Charles' decision.
Elderly Medicare beneficiaries are more satisfied with their health care, and experience fewer problems accessing and paying for care, than Americans with employer-sponsored insurance (ESI), according to a study by Commonwealth Fund researchers published today on the Health Affairs Web site.
For the estimated 220,000 men who will be diagnosed with prostate cancer this year, deciding on a method of treatment can be a challenge. Some with early-stage cancer pursue a "wait and watch" option, also called active surveillance, while others with more severe cancer immediately pursue surgery, including prostatectomy (removal of the prostate).
› Verified 3 days ago